SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Compdent (CPDN) -- Ignore unavailable to you. Want to Upgrade?

To: dowman who wrote (8)2/18/1998 12:03:00 PM
From: van wang  Read Replies (1) | Respond to of 18
 
the stock was undervalued...it was trading at 5X EBITDA which in wall street terms a SLAM DUNK...also the stock has low to negative beta...trades at low price to book, low pe to expected growth...hence the 40% move since last week...btw, I believe more than five entities have taken 13G positions on this company...lets hang on for the ride...we could see 20 soon enough by the way the charts look

bibifn



To: dowman who wrote (8)2/18/1998 1:03:00 PM
From: battle beast  Respond to of 18
 
I don't know what is causing the runup. Little investors like you (I assume) and me are always the last to know. But I do know that even with the recent runup, CPDN is trading at around book value and its price/sale ratio is still less than 1. I consider this stock is still cheap.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News